Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.15
OCR's Cash to Debt is ranked lower than
62% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 0.29 vs. OCR: 0.15 )
Ranked among companies with meaningful Cash to Debt only.
OCR' s Cash to Debt Range Over the Past 10 Years
Min: 0.05  Med: 0.15 Max: 67.66
Current: 0.15
0.05
67.66
Equity to Asset 0.41
OCR's Equity to Asset is ranked lower than
53% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. OCR: 0.41 )
Ranked among companies with meaningful Equity to Asset only.
OCR' s Equity to Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.50 Max: 0.88
Current: 0.41
0.31
0.88
F-Score: 6
Z-Score: 3.31
M-Score: -2.78
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 6.23
OCR's Operating margin (%) is ranked lower than
58% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 7.46 vs. OCR: 6.23 )
Ranked among companies with meaningful Operating margin (%) only.
OCR' s Operating margin (%) Range Over the Past 10 Years
Min: 1.33  Med: 6.83 Max: 9.86
Current: 6.23
1.33
9.86
Net-margin (%) 2.57
OCR's Net-margin (%) is ranked lower than
61% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. OCR: 2.57 )
Ranked among companies with meaningful Net-margin (%) only.
OCR' s Net-margin (%) Range Over the Past 10 Years
Min: -1.73  Med: 2.26 Max: 4.28
Current: 2.57
-1.73
4.28
ROE (%) 6.58
OCR's ROE (%) is ranked lower than
61% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 9.24 vs. OCR: 6.58 )
Ranked among companies with meaningful ROE (%) only.
OCR' s ROE (%) Range Over the Past 10 Years
Min: -2.76  Med: 4.69 Max: 9.3
Current: 6.58
-2.76
9.3
ROA (%) 2.71
OCR's ROA (%) is ranked lower than
57% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 3.42 vs. OCR: 2.71 )
Ranked among companies with meaningful ROA (%) only.
OCR' s ROA (%) Range Over the Past 10 Years
Min: -1.44  Med: 2.07 Max: 4.1
Current: 2.71
-1.44
4.1
ROC (Joel Greenblatt) (%) 33.93
OCR's ROC (Joel Greenblatt) (%) is ranked higher than
66% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 19.71 vs. OCR: 33.93 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
OCR' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 3.81  Med: 26.72 Max: 36.39
Current: 33.93
3.81
36.39
Revenue Growth (3Y)(%) 3.90
OCR's Revenue Growth (3Y)(%) is ranked lower than
68% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. OCR: 3.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
OCR' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -0.4  Med: 11.10 Max: 40.5
Current: 3.9
-0.4
40.5
EBITDA Growth (3Y)(%) 3.70
OCR's EBITDA Growth (3Y)(%) is ranked lower than
66% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. OCR: 3.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
OCR' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -21.8  Med: 6.50 Max: 37.6
Current: 3.7
-21.8
37.6
EPS Growth (3Y)(%) 7.30
OCR's EPS Growth (3Y)(%) is ranked lower than
57% of the 121 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. OCR: 7.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
OCR' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -49.6  Med: 4.90 Max: 86.6
Current: 7.3
-49.6
86.6
» OCR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2014

OCR Guru Trades in Q4 2014

Louis Moore Bacon 165,000 sh (New)
Jim Simons 1,531,600 sh (+36.05%)
First Eagle Investment 844,500 sh (unchged)
Ray Dalio Sold Out
Joel Greenblatt Sold Out
Chuck Royce 51,199 sh (-2.29%)
James Barrow 4,807,769 sh (-4.98%)
Pioneer Investments 636,307 sh (-9.80%)
» More
Q1 2015

OCR Guru Trades in Q1 2015

Joel Greenblatt 337,773 sh (New)
First Eagle Investment 844,500 sh (unchged)
Louis Moore Bacon Sold Out
Chuck Royce Sold Out
James Barrow 4,801,304 sh (-0.13%)
Pioneer Investments 629,794 sh (-1.02%)
Jim Simons 698,100 sh (-54.42%)
» More
Q2 2015

OCR Guru Trades in Q2 2015

Paul Tudor Jones 353,628 sh (New)
Mario Gabelli 408,800 sh (New)
Jeremy Grantham 547,000 sh (New)
Joel Greenblatt 861,946 sh (+155.18%)
First Eagle Investment Sold Out
Jim Simons Sold Out
James Barrow 2,955,731 sh (-38.44%)
Pioneer Investments 80,189 sh (-87.27%)
» More
Q3 2015

OCR Guru Trades in Q3 2015

Mario Gabelli Sold Out
Paul Tudor Jones Sold Out
Joel Greenblatt Sold Out
Jeremy Grantham Sold Out
Pioneer Investments Sold Out
James Barrow Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with OCR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Omnicare Inc

Mario Gabelli Comments on Omnicare Inc. - Oct 19, 2015

Omnicare, Inc. (NYSE:OCR) is a Cincinnati, Ohio based pharmaceutical services provider. On May 21, 2015, CVS Health announced that it would acquire Omnicare for $98 cash per share in a $9.5 billion merger. The Omnicare acquisition expands CVS into the long term care pharmacy dispensing channel. The deal received regulatory and shareholder approvals and was completed on August 18, 2015.The Fund earned an 8.46% annualized return.



From Mario Gabelli (Trades, Portfolio)'s ABC Fund third quarter commentary.



Check out Mario Gabelli latest stock trades

Top Ranked Articles about Omnicare Inc

Mario Gabelli Comments on Omnicare Inc. Guru stock highlight
Omnicare, Inc. (NYSE:OCR) is a Cincinnati, Ohio based pharmaceutical services provider. On May 21, 2015, CVS Health announced that it would acquire Omnicare for $98 cash per share in a $9.5 billion merger. The Omnicare acquisition expands CVS into the long term care pharmacy dispensing channel. The deal received regulatory and shareholder approvals and was completed on August 18, 2015.The Fund earned an 8.46% annualized return. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 60.50
OCR's P/E(ttm) is ranked lower than
86% of the 271 Companies
in the Global Medical Care industry.

( Industry Median: 23.30 vs. OCR: 60.50 )
Ranked among companies with meaningful P/E(ttm) only.
OCR' s P/E(ttm) Range Over the Past 10 Years
Min: 10.93  Med: 26.11 Max: 122.41
Current: 60.5
10.93
122.41
Forward P/E 21.05
OCR's Forward P/E is ranked lower than
78% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 15.82 vs. OCR: 21.05 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 60.10
OCR's PE(NRI) is ranked lower than
84% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 23.30 vs. OCR: 60.10 )
Ranked among companies with meaningful PE(NRI) only.
OCR' s PE(NRI) Range Over the Past 10 Years
Min: 9.68  Med: 26.10 Max: 639.6
Current: 60.1
9.68
639.6
P/B 3.72
OCR's P/B is ranked lower than
76% of the 301 Companies
in the Global Medical Care industry.

( Industry Median: 2.42 vs. OCR: 3.72 )
Ranked among companies with meaningful P/B only.
OCR' s P/B Range Over the Past 10 Years
Min: 0.6  Med: 1.13 Max: 3.72
Current: 3.72
0.6
3.72
P/S 1.55
OCR's P/S is ranked lower than
61% of the 305 Companies
in the Global Medical Care industry.

( Industry Median: 1.23 vs. OCR: 1.55 )
Ranked among companies with meaningful P/S only.
OCR' s P/S Range Over the Past 10 Years
Min: 0.33  Med: 0.65 Max: 1.55
Current: 1.55
0.33
1.55
PFCF 21.90
OCR's PFCF is ranked lower than
56% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 20.58 vs. OCR: 21.90 )
Ranked among companies with meaningful PFCF only.
OCR' s PFCF Range Over the Past 10 Years
Min: 4.79  Med: 10.06 Max: 71.06
Current: 21.9
4.79
71.06
POCF 19.35
OCR's POCF is ranked lower than
67% of the 281 Companies
in the Global Medical Care industry.

( Industry Median: 13.69 vs. OCR: 19.35 )
Ranked among companies with meaningful POCF only.
OCR' s POCF Range Over the Past 10 Years
Min: 4.29  Med: 8.97 Max: 50.64
Current: 19.35
4.29
50.64
EV-to-EBIT 27.28
OCR's EV-to-EBIT is ranked lower than
74% of the 297 Companies
in the Global Medical Care industry.

( Industry Median: 17.78 vs. OCR: 27.28 )
Ranked among companies with meaningful EV-to-EBIT only.
OCR' s EV-to-EBIT Range Over the Past 10 Years
Min: 9.2  Med: 15.70 Max: 94.7
Current: 27.28
9.2
94.7
EV-to-EBITDA 20.72
OCR's EV-to-EBITDA is ranked lower than
79% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 12.42 vs. OCR: 20.72 )
Ranked among companies with meaningful EV-to-EBITDA only.
OCR' s EV-to-EBITDA Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 20.72
Current: 20.72
0
20.72
PEG 7.71
OCR's PEG is ranked lower than
88% of the 75 Companies
in the Global Medical Care industry.

( Industry Median: 2.70 vs. OCR: 7.71 )
Ranked among companies with meaningful PEG only.
OCR' s PEG Range Over the Past 10 Years
Min: 0.86  Med: 2.98 Max: 2287
Current: 7.71
0.86
2287
Shiller P/E 89.70
OCR's Shiller P/E is ranked lower than
90% of the 70 Companies
in the Global Medical Care industry.

( Industry Median: 28.25 vs. OCR: 89.70 )
Ranked among companies with meaningful Shiller P/E only.
OCR' s Shiller P/E Range Over the Past 10 Years
Min: 11.55  Med: 23.14 Max: 89.83
Current: 89.7
11.55
89.83
Current Ratio 1.65
OCR's Current Ratio is ranked higher than
66% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.33 vs. OCR: 1.65 )
Ranked among companies with meaningful Current Ratio only.
OCR' s Current Ratio Range Over the Past 10 Years
Min: 0.9  Med: 3.37 Max: 9.8
Current: 1.65
0.9
9.8
Quick Ratio 1.18
OCR's Quick Ratio is ranked lower than
52% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. OCR: 1.18 )
Ranked among companies with meaningful Quick Ratio only.
OCR' s Quick Ratio Range Over the Past 10 Years
Min: 0.73  Med: 2.76 Max: 9.04
Current: 1.18
0.73
9.04
Days Inventory 33.05
OCR's Days Inventory is ranked lower than
66% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 16.82 vs. OCR: 33.05 )
Ranked among companies with meaningful Days Inventory only.
OCR' s Days Inventory Range Over the Past 10 Years
Min: 30.11  Med: 34.73 Max: 37.68
Current: 33.05
30.11
37.68
Days Sales Outstanding 33.96
OCR's Days Sales Outstanding is ranked higher than
66% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 46.01 vs. OCR: 33.96 )
Ranked among companies with meaningful Days Sales Outstanding only.
OCR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 32.92  Med: 66.45 Max: 86.94
Current: 33.96
32.92
86.94
Days Payable 20.69
OCR's Days Payable is ranked lower than
74% of the 146 Companies
in the Global Medical Care industry.

( Industry Median: 42.47 vs. OCR: 20.69 )
Ranked among companies with meaningful Days Payable only.
OCR' s Days Payable Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 0
Current: 20.69

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.88
OCR's Dividend Yield is ranked lower than
81% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 2.01 vs. OCR: 0.88 )
Ranked among companies with meaningful Dividend Yield only.
OCR' s Dividend Yield Range Over the Past 10 Years
Min: 0.15  Med: 0.41 Max: 1.32
Current: 0.88
0.15
1.32
Dividend Payout 0.53
OCR's Dividend Payout is ranked lower than
60% of the 146 Companies
in the Global Medical Care industry.

( Industry Median: 0.71 vs. OCR: 0.53 )
Ranked among companies with meaningful Dividend Payout only.
OCR' s Dividend Payout Range Over the Past 10 Years
Min: 0.03  Med: 0.10 Max: 0.95
Current: 0.53
0.03
0.95
Dividend Growth (3y) 75.00
OCR's Dividend Growth (3y) is ranked higher than
97% of the 67 Companies
in the Global Medical Care industry.

( Industry Median: 11.90 vs. OCR: 75.00 )
Ranked among companies with meaningful Dividend Growth (3y) only.
OCR' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 4.00 Max: 78
Current: 75
0
78
Yield on cost (5-Year) 10.34
OCR's Yield on cost (5-Year) is ranked higher than
92% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 2.46 vs. OCR: 10.34 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
OCR' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.76  Med: 4.82 Max: 15.52
Current: 10.34
1.76
15.52
3-Year Average Share Buyback Ratio 2.50
OCR's 3-Year Average Share Buyback Ratio is ranked higher than
92% of the 120 Companies
in the Global Medical Care industry.

( Industry Median: -2.20 vs. OCR: 2.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
OCR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -11  Med: -2.10 Max: 2.5
Current: 2.5
-11
2.5

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.64
OCR's Price/Projected FCF is ranked lower than
62% of the 172 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. OCR: 1.64 )
Ranked among companies with meaningful Price/Projected FCF only.
OCR' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.39  Med: 0.84 Max: 7.87
Current: 1.64
0.39
7.87
Price/Median PS Value 2.38
OCR's Price/Median PS Value is ranked lower than
95% of the 301 Companies
in the Global Medical Care industry.

( Industry Median: 1.00 vs. OCR: 2.38 )
Ranked among companies with meaningful Price/Median PS Value only.
OCR' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.55  Med: 1.47 Max: 7.06
Current: 2.38
0.55
7.06
Price/Peter Lynch Fair Value 3.12
OCR's Price/Peter Lynch Fair Value is ranked lower than
67% of the 90 Companies
in the Global Medical Care industry.

( Industry Median: 2.16 vs. OCR: 3.12 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
OCR' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.48  Med: 1.90 Max: 12.47
Current: 3.12
0.48
12.47
Earnings Yield (Greenblatt) (%) 3.70
OCR's Earnings Yield (Greenblatt) (%) is ranked lower than
56% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. OCR: 3.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
OCR' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.1  Med: 6.40 Max: 10.8
Current: 3.7
1.1
10.8
Forward Rate of Return (Yacktman) (%) 23.60
OCR's Forward Rate of Return (Yacktman) (%) is ranked higher than
84% of the 101 Companies
in the Global Medical Care industry.

( Industry Median: 10.86 vs. OCR: 23.60 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
OCR' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -4.3  Med: 9.70 Max: 23.8
Current: 23.6
-4.3
23.8

More Statistics

Revenue(Mil) $6629
EPS $ 1.62
Short Percentage of Float10.12%
52-Week Range $59.85 - 97.98
Shares Outstanding(Mil)96.89

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 6,797 7,137 7,582
EPS($) 3.96 4.65 5.34
EPS without NRI($) 3.96 4.65 5.34

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:OMN.Germany,
Omnicare Inc was formed in 1981 in Delaware. It is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group and Specialty Care Group. Through Long-Term Care Group, the Company provides pharmaceuticals and related pharmacy services to long-term care facilities as well as chronic care facilities and other settings. Through Specialty Care Group, the Company provides specialty pharmacy and commercialization services for the biopharmaceutical industry. The Company's businesses engage in an ongoing program for the development and marketing of new services. The Company serves long-term care institutions and other chronic care settings in approximately 47 states in the U.S. and the District of Columbia. The Company's largest competitor nationally is PharMerica Corporation. It also competes with numerous local and regional institutional pharmacies, pharmacies owned by long-term care facilities and local retail pharmacies. The Company is subject to extensive federal, state and local regulation.
» More Articles for OCR

Headlines

Articles On GuruFocus.com
Paul Tudor Jones Exits Positions in Motorola, Pall Corp. Dec 08 2015 
Walgreens Buys Rite Aid to Avoid Loose Market Nov 04 2015 
Mario Gabelli Comments on Omnicare Inc. Oct 19 2015 
The Gabelli ABC Merger and Arbitrage Fund Q3 Shareholder Commentary Oct 19 2015 
Broadcom, Pall Corp. Among Paul Tudor Jones' Recent Buys Sep 20 2015 
GAMCO Investors' Top Buys in Q2 2015 Aug 09 2015 
Mario Gabelli’s GAMCO Buys 35 New Stocks in 2nd Quarter Aug 05 2015 
First Eagle Fund of America Second Quarter Commentary and Outlook Aug 03 2015 
Mario Gabelli's ABC Fund Merger and Arbitrage 'The Deal Fund' Q2 Commentary Jul 23 2015 
CVS Eyeing Omnicare Acquisition To Bolster Market Position May 23 2015 

More From Other Websites
Walgreens Boots to buy Rite Aid in $17.2 bn deal Oct 27 2015
Tailwind Capital Expands its Healthcare Team Oct 21 2015
OMNICARE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... Oct 14 2015
CVS Health Corporation Announces Results to Date of Exchange Offers and Consent Solicitations Oct 09 2015
Omnicare Trust PIERS to Accrue Contingent Interest Sep 15 2015
Omnicare Trust PIERS to Accrue Contingent Interest Sep 15 2015
OMNICARE INC Financials Aug 22 2015
Omnicare Announces Conversion Rate Adjustments for Convertible Notes Aug 18 2015
Omnicare Announces Conversion Rate Adjustments for Convertible Notes Aug 18 2015
OMNICARE INC Files SEC form 8-K, Financial Statements and Exhibits Aug 18 2015
Omnicare Announces Conversion Rate Adjustments for Convertible Notes Aug 18 2015
CVS Health Completes Omnicare Acquisition Aug 18 2015
Care Capital Properties Set to Join the S&P MidCap 400 Aug 12 2015
Omnicare (OCR) is in Overbought Territory: What's Next? Aug 12 2015
McKesson Corp. Earnings Analysis: By the Numbers Q2*, 2015 Aug 07 2015
OMNICARE INC Files SEC form 8-K, Other Events Aug 06 2015
CVS Eyes Specialty Pharmacy Opportunity through Acquisitions Aug 06 2015
Mario Gabelli's Top 5 New Stock Buys of Q2 Aug 05 2015
Express Scripts Holding Co. Earnings Q2*, 2015 Aug 04 2015
LALT: A True Hedge ETF Jul 31 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK